Relationship between WT1 gene mutation and prognosis of acute myeloid leukemia: a Meta鄄analysis
10.3760/cma.j.issn.1009_9921.2019.04.008
- VernacularTitle:WT1基因突变与急性髓系白血病预后关系的Meta分析
- Author:
Jing XU
1
;
Zhifang XU
;
Jinjun HU
;
Hongwei WANG
Author Information
1. 山西医科大学第二临床医学院
- Keywords:
Leukemia,myeloid,acute;
Gene,WT1;
Prognosis;
Meta_analysis
- From:
Journal of Leukemia & Lymphoma
2019;28(4):227-232
- CountryChina
- Language:Chinese
-
Abstract:
Objective To summarize the relationship between WT1 gene mutation and prognosis of acute myeloid leukemia (AML). Methods The related literatures were searched in PubMed, Google Scholar and Cochrane Library databases, and the deadline was April 2, 2018. The Meta_analysis was performed by using Review Manager 5.2 software. Results A total of 9 literatures were included. Meta analysis showed that for the pediatric AML patients, the overall survival (OS) time in the WT1 gene mutated group was shorter than that in the wild_type group ( HR＝1.41, 95% CI 1.07-1.87, P＝0.01). For the total AML patients, the relapse_free survival (RFS) time in the WT1 gene mutated group was shorter than that in the wild_type group ( HR＝2.21, 95% CI 1.15-3.93, P＝0.02), but there was no significant difference in OS and disease_free survival (DFS) time between the two groups ( HR＝1.65, 95% CI 0.97-2.80, P＝0.06; HR＝0.46, 95% CI 0.08-2.57, P＝0.38). For the AML patients with normal karyotype and adult AML patients, there was no difference in OS time between the WT1 gene mutated group and wild_type group ( HR＝ 2.66, 95% CI 0.57-12.31, P＝ 0.21;HR＝ 2.10, 95% CI 0.70-6.30, P＝ 0.18). Conclusion WT1 gene mutation is a risk factor affecting OS of pediatric AML patients and RFS of general AML patients.
